Market Access Agenda in Europe – A Video Interview on EU HTA

Author: Dr. Matthias Schönermark

Insightful discussion with Prof. Dr. Matthias P. Schönermark, and Oznur Seyhun, Partner & Anchorwoman at Market Access Today.

Video interview on EU HTA

You can watch the video using the player below:

Topics

The interview covers the following topics:

Introduction to Prof. Dr. Matthias P. Schönermark: Discover the impressive career journey of Prof. Schönermark and his significant contributions to the field of health technology assessment (HTA).
Impact of European HTA Regulation: With the European Health Technology Assessment Regulation now effective for oncology drugs and advanced therapy medicinal products (ATMPs), Prof. Schönermark discusses the anticipated impacts on industry practices and patient access.
Implications of the Implementing Act: After some delays, the Implementing Act on the Design of Joint Clinical Assessments was recently published in April. Learn about its implications and how it is prepared to enhance the implementation of the European HTA Regulation across Member States.
Future Trends in Patient Access: Prof. Schönermark outlines the trends he foresees in Europe regarding securing adequately funded patient access and how he sees the European HTA fitting within the broader organisation.

Source: Market Access Today

Our expertise:

Strategic Advisory

We are your partner in overcoming the complexities of European markets, offering customised solutions to guide you seamlessly through every step of the patient access journey from development and registration through access and launch preparedness.

View service

National Market Access Strategy & Negotiation

Your path to success begins with a clear, well-defined strategy. At Kintiga, we combine local insights with therapeutic expertise to unlock Europe’s healthcare markets.

View service

EU-HTA

Our European team expertly navigates the complexities of EU HTA procedures, providing both strategic guidance & comprehensive end-to-end support for JSCs & JCAs at every stage of the process. We are committed to ensuring your products reach patients across Europe efficiently & effectively.

View service

Pricing Strategy

Our experts start with what matters most to access stakeholders and work backwards to develop robust pricing and reimbursement strategies tailored to each market to reflect the value for your product.

View service

Value Communication & Stakeholder Management

We transform complex evidence into compelling, compliant narratives. Through evidence-based storytelling and stakeholder input, we help your product achieve its full potential across diverse markets.

View service

HEOR & Modelling

At Kintiga our expertise in modelling data, outcomes, and costs provides stakeholders with clarity to fully understand the value of treatments, which is vital for healthcare decision making.

View service